Theseus Pharmaceuticals Appoints Tim Clackson, Ph.D., as Chief Executive Officer
Share this article CAMBRIDGE, Mass., May 4, 2021 /PRNewswire/ -- Theseus Pharmaceuticals, a biotechnology company shaping the future of targeted oncology by developing best-in-class, pan-variant kinase inhibitors, today announced the appointment of Tim Clackson, Ph.D., as Chief Executive Officer and as a member of the Company's Board of Directors. He succeeds interim CEO Iain Dukes, D.Phil., Theseus Co-Founder and OrbiMed Venture Partner, who will serve as Theseus' Executive Chairman. "I am thrilled to join the team of R&D leaders at Theseus, who have a proven track record and share my pass...
Source: prnewswire.com